home / stock / apm / apm news

APM News and Press, Aptorum Group Limited

Stock Information
Company Name: Aptorum Group Limited
Stock Symbol: APM
Market: NASDAQ
Website: aptorumgroup.com
Menu
APM APM Quote APM Short APM News APM Articles APM Message Board
Get APM Alerts

News, Short Squeeze, Breakout and More Instantly...
APM - Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences Corp. ( ...
APM - Aptorum receives Nasdaq notice over minimum bid price requirement

2026-03-06 16:35:12 ET More on Aptorum Group Seeking Alpha’s Quant Rating on Aptorum Group Financial information for Aptorum Group Read the full article on Seeking Alpha For further details see: Aptorum receives Nasdaq notice over minimum bid price...

APM - Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

NEW YORK, NY; NEW HAVEN, CT; PRINCETON, NJ, and TAIPEI, TAIWAN, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, DiamiR Biosciences Cor...

APM - DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or &#x...
APM - US Companies Moving the Markets, Evening edition
Fri, Oct 10, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 19.3% to $4.94 on volume of 469,328,303 shares AiRWA Inc. (YYAI) fell 9.1% to $0.1899 on volume of 426,962,571 shares PROSHARES TRUST (SQQQ) rose 10.6% to $16.03 on volume of 277,7...

APM - Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering

$2 million upfront with up to additional $4 million of potential aggregate gross proceeds upon the exercise in full of warrants NEW YORK, NY, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group” or “Aptorum”), a clinical stage bi...

APM - As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives

NEW YORK, NY, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, announces the addition of Dr. Laura A. Philips to its board of directors...
APM - Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences Corp. ( ...

APM - Aptorum Group regains compliance with Nasdaq's minimum bid price rule

2025-08-04 09:06:21 ET More on Aptorum Group Aptorum Group and Diamir Biosciences enter into merger agreement Financial information for Aptorum Group Read the full article on Seeking Alpha For further details see: Aptorum Group regains compliance with Nas...

APM - Aptorum Group Limited Regains Compliance with NASDAQ's Minimum Bid Price Requirement

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that it received formal written notification from Th...
Next 10